相关实验视频

Updated: Apr 7, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

关于茶叶多相关天然产品抗SARS-CoV-2机制的系统研究

Chen-Wei Li¹, Tai-Ling Chao², Chin-Lan Lai¹

¹Institute of Biochemical Sciences, National Taiwan University, Taipei 10617, Taiwan.

|June 10, 2024

概括

这项研究引入了一个系统的协议,以澄清茶叶聚醇对SARS-CoV-2的抗病毒机制. 该方法有助于区分阻断病毒进入和抑制这些多目标化合物的病毒复制.

科学领域:

病毒学病毒学
自然产品化学自然产品化学
药物发现药物发现药物发现

背景情况:

严重急性呼吸道综合征-冠状病毒-2 (SARS-CoV-2) 使用其尖端蛋白的受体结合域 (RBD) 结合人类ACE2,促进病毒的进入.
病毒复制涉及蛋白酶 (3CLpro,PLpro) 的多蛋白质成熟和由依赖RNA的RNA聚合酶 (RdRp) 合成病毒RNA.
与茶叶聚相关的天然产品对SARS-CoV-2表现出抗病毒活性,但由于多目标性质,它们的精确机制往往不清楚.

研究的目的:

开发和验证一种系统的协议,以阐明天然产品衍生抗病毒药物的抗SARS-CoV-2机制.
要区分抑制病毒进入的化合物 (例如,阻断RBD/ACE2相互作用,蛋白酶抑制) 和抑制病毒复制的化合物.

主要方法:

利用各种体外测试来测试与茶叶聚相关的天然产品.
评估了这些化合物的阻断SARS-CoV-2 RBD/ACE2相互作用的能力.
评估了宿主细胞蛋白酶 (furin,TMPRSS2,cathepsin L) 和病毒蛋白酶 (3CLpro,PLpro) 的抑制.
确定了对病毒复制的影响,包括RdRp活动.

主要成果:

已确定有效的抗病毒药物,通过抑制RBD/ACE2相互作用和/或宿主蛋白酶来防止SARS-CoV-2的进入.
观察到一些化合物还抑制了对复制至关重要的病毒酶,导致对其主要机制的误解.
演示了开发协议在澄清不同抗病毒作用时的实用性.

结论:

开发的系统协议有效地阐明了多目标天然产品的抗SARS-CoV-2机制.
这种方法对于准确阐明药物机制至关重要,并且适用于广泛的抗病毒药物.
为了解天然产品如何对抗SARS-CoV-2提供了一个框架,帮助未来的药物开发工作.

更多相关视频

Study on the Metabolism of Six Systemic Insecticides in a Newly Established Cell Suspension Culture Derived from Tea Camellia Sinensis L. Leaves

Study on the Metabolism of Six Systemic Insecticides in a Newly Established Cell Suspension Culture Derived from Tea Camellia Sinensis L. Leaves

Published on: June 15, 2019

Author Spotlight: Exploring Tea Aroma Using Solvent-Assisted Flavor Evaporation Technique

Author Spotlight: Exploring Tea Aroma Using Solvent-Assisted Flavor Evaporation Technique

Published on: May 26, 2023

相关概念视频

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...